Skip to main content
Equibles
OHI logo

OHI · Omega Healthcare Investors Inc

Track OHI — free

Use OHI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about OHI

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$46.53 +0.52 (+1.13%) At close · Aug 14
Market Cap
$13.90B
Shares
303.01M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$46.53 Open$46.03 Day$45.72–46.71 52W close$39.41–51.72 Avg vol 30d1.8M Short int12.9M · 4.2% float · 6.1d Short vol57% Last earningsJul 30, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 30

Up next

Next earnings call
Oct 30, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Jul 30, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very Low
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg +1%
      above
      Price vs 50-day avg −3%
      below
      RSI (14) 38
      neutral
      MACD trend Negative
      52-week position 58%
      mid-range
      Momentum
      relative strength
      Weak
      1-month return −7%
      trailing
      6-month return −1%
      trailing
      YTD return +5%
      this year
      Relative strength −15%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $48 › 200d $46 — 50d above 200d
      Institutional flow Distributing
      -1% holders QoQ · +86 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      4.25% of float · ▼ -2.9% MoM · 6.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      745 holders — near 3-yr high, broad support
      Squeeze score 58
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +13%
      Y/Y
      EPS growth +25%
      Y/Y
      Valuation P/E 16.3
      below peers
      Buyback $500.0M
      authorized
      Balance sheet $4.2B
      net debt
      Quant / Vol
      risk profile
      Very Low
      Volatility 21%
      annualized · 1-yr
      Max drawdown −12%
      past year
      ATR 2.3%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Apr 28, 2026
      Adjusted FFO · full year 2026 Non-GAAP $3.22
      Prior guidance period ended · from the 8-K filed Oct 30, 2025
      Adjusted FFO (AFFO) per share · full year 2025 $3.08 – $3.10

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +1% Bullish
      Price vs 50-day avg
      −3% Neutral
      RSI (14)
      38 Neutral
      MACD trend
      Negative Bearish
      52-week position
      58% Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $48 › 200d $46 — 50d above 200d
      Institutional flow Distributing
      -1% holders QoQ · +86 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      4.25% of float · ▼ -2.9% MoM · 6.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      745 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $39 Now $47 · 58% Range high $52
      vs 200-day avg +1% vs 50-day avg -3%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      GAAP → non-GAAP reconciliation
      GAAP Nareit FFO 223.96M
      +18.87M Severance expense
      +8.74M Stock-based compensation expense
      +7.39M Straight-line rent and other write-offs
      +4.66M Acquisition, merger and transition related costs
      +516K Other normalizing items – net
      -2.78M Non-cash (recovery) provision for credit losses
      = Adjusted funds from operations ("AFFO") 261.36M
      AFFO per diluted share non-GAAP $0.83 Q2 2026 —
      Net Operating Income (NOI) non-GAAP 331M Q2 2026 —
      Weighted-average common shares outstanding 316M Q2 2026 —
      Adjusted Funds From Operations (full year) non-GAAP $946M FY 2025 —
      Aggregate debt repaid (Q4) $1.27B Q4 2025 —
      ATM Program size (new) $2B Q4 2025 —
      Delayed draw unsecured term loan facility drawn $300M Q4 2025 —
      FAD per diluted share (full year) non-GAAP $2.96 FY 2025 —
      Funds Available for Distribution (full year) non-GAAP $903M FY 2025 —
      New investments completed (full year) $1.1B FY 2025 —
      Omega OP Units issued (Q4) 5.5M Q4 2025 —
      Saber JV contractual rent per annum $70.2M FY 2025 —
      Saber JV number of facilities 65 FY 2025 —
      Saber JV weighted average interest rate 5.7% FY 2025 —
      Senior unsecured credit facility size (new) $2.3B FY 2025 —
      Value of Omega OP Units issued $222M Q4 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      OHI
      Omega Healthcare Investors Inc
      this stock
      		$13.90B +4.9% +13.2% 16.3 4.2%
      WELL
      Welltower Inc.
      		 $162.55B +26.9% +35.6% 114.6 2.5%
      VTR
      Ventas, Inc.
      		 $45.66B +18.3% +18.5% 164.8 4.6%
      DOC
      Healthpeak Properties, Inc.
      		 $14.34B +29.3% +4.5% 59.4 3.5%
      AHR
      American Healthcare REIT, Inc.
      		 $11.83B +15.4% +9.1% 78.6 10.2%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      745
      % held
      81.8%
      Net QoQ
      +11.6M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      659
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      12.9M
      Days to cover
      6.1d
      Change
      -379.2K sh
      View
      Short Volume
      Short vol %
      57%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      709
      Value
      $34.2K
      As of
      Jul 13, 2026
      View
      Off-Exchange
      Off-exchange %
      38.1%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Daniel Goldman
      Amount
      $1.0K–$15.0K
      Traded
      Mar 7, 2023
      View
      Financials
      Financials
      Revenue (FY)
      $1.2B
      Net income (FY)
      $590.2M
      EPS diluted
      $1.94
      View
      Buybacks
      Authorized
      $500.0M
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Jul 30, 2026
      This year
      10
      View
      Proposed Sales
      Value
      $100.9K
      Shares
      2.5K
      Filed
      Aug 8, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 30, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      OHI -4.0% -7.3% -1.1% -8.1% +4.9%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -4.4% -11.8% -14.8% -12.0% -8.9%

      Capital returns

      Latest dividend
      $0.68 / share · ex Aug 3, 2026
      Raised 1.5%
      Paid (TTM)
      $2.69 / share · 4 payouts
      Dividend yield (TTM, derived)
      5.78%
      Buyback program · as of Jun 30, 2025
      Authorized
      $500.00M
      Spent (derived)
      —
      Remaining
      —

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 888491 CUSIP 681936100 13F (30d) 707 filings 672 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)